Amarin reported $3.37M in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Amarin USD 3.37M 3.37M Dec/2024
AstraZeneca USD 85M 17M Sep/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
DBV Technologies USD -0.32 0.02 Sep/2024
Esperion Therapeutics USD -0.15 0.18 Sep/2024
GlaxoSmithKline GBP 26M 24M Sep/2025
Heron Therapeutics USD 433K 277K Dec/2021
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Nektar Therapeutics USD -0.18 0.07 Sep/2024